Tapewire

Nasdaq · USD

AMGN

AMGEN INC

Export transactions ↓
Tapewire entity
2832
SEC CIK
0000318154
Parsed reports
1,877

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202500
Jan 202600
Feb 202603
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202606
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 05, 2005 Filed May 9, 2005 16:25 UTC OtherCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001181431-05-026534 · rrd78104.xml · nonDerivative · entry 1

JOHNSON FRANKLIN P JR · CIK 0000904017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 721,749

F1 · kind: (FPJ-05/05-Dist.) On May 5, 2005, Asset Management Partners ("AMP") distributed shares of Amgen Common Stock to the partners of the partnership. Accordingly, 8,000 shares are now held directly by each of the reporting person and his spouse, and 8,000 shares were distributed to the other partners. AMP, of which the reporting person is the general partner, holds 576,000 shares of Amgen Common Stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange of 1934, as amended.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
Exercise / conversionNQSO (Right to Buy) · Derivative 4,000 $0.00 Strike: $38.36 $0.00
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · derivative · entry 13

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,159

Underlying: Common Stock · 4,000 shares

Expires 2009-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
Exercise / conversionNQSO (Right to Buy) · Derivative 22,358 $0.00 Strike: $30.44 $0.00
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · derivative · entry 12

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,358 shares

Expires 2006-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
Exercise / conversionISO (Right to Buy) · Derivative 2,608 $0.00 Strike: $38.36 $0.00
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · derivative · entry 11

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1

Underlying: Common Stock · 2,608 shares

Expires 2009-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
Exercise / conversionISO (Right to Buy) · Derivative 1,642 $0.00 Strike: $30.44 $0.00
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · derivative · entry 10

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,642 shares

Expires 2006-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
Exercise / conversionISO (Right to Buy) · Derivative 3,052 $0.00 Strike: $16.38 $0.00
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · derivative · entry 9

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,052 shares

Expires 2005-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
OtherCommon Stock 3,224.201 $0.00 $0.00
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 8

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401(k) Plan

Disclosed balance after: 3,224.201

F3 · balance_after: (KWS 401(k)) These are units acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
GiftCommon Stock 33,660 $0.00 $0.00
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 7

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Indirect · Living Trust

Disclosed balance after: 66,751

F1 · shares: (KWS 4.29.05) Transfer of shares into reporting person's living trust.

F2 · balance_after: (KWS 2.14.05) The amount of the Company's Common Stock beneficially owned has been adjusted to reflect an acquisition by the reporting person of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(1)(k)(B) and subsequent transfer of such shares to reporting person's living trust.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
GiftCommon Stock 33,660 $0.00 $0.00
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 6

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: (KWS 4.29.05) Transfer of shares into reporting person's living trust.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
Exercise / conversionCommon Stock 4,000 $38.36 $153,440.00
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 5

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
Exercise / conversionCommon Stock 22,358 $30.44 $680,521.63
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 4

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
Exercise / conversionCommon Stock 2,608 $38.36 $100,042.88
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 3

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,302

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
Exercise / conversionCommon Stock 1,642 $30.44 $49,978.38
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 2

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,694

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 29, 2005 Filed May 3, 2005 16:44 UTC
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
Exercise / conversionCommon Stock 3,052 $16.38 $49,976.50
Disclosure

SEC source: 0001181431-05-025015 · rrd77343.xml · nonDerivative · entry 1

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,052

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC Exercise / conversionNQSO (Right to Buy) · Derivative 124,800 $0.00 Strike: $55.39 $0.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · derivative · entry 19

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,200

Underlying: Common Stock · 124,800 shares

Expires 2012-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC Exercise / conversionNQSO (Right to Buy) · Derivative 27,000 $0.00 Strike: $31.07 $0.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · derivative · entry 18

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,000 shares

Expires 2010-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC SaleCommon Stock 20,000 $58.00 $1,160,002.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 13

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,000

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC SaleCommon Stock 20,000 $58.17 $1,163,342.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 12

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,000

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC SaleCommon Stock 20,000 $58.04 $1,160,714.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 11

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,000

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC SaleCommon Stock 20,000 $58.03 $1,160,540.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 10

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,000

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC SaleCommon Stock 10,000 $58.21 $582,127.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 9

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,000

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC SaleCommon Stock 14,800 $58.05 $859,140.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 8

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 321,000

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC SaleCommon Stock 5,000 $57.57 $287,850.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 7

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,800

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC SaleCommon Stock 5,000 $57.50 $287,500.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 6

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340,800

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC SaleCommon Stock 7,000 $57.70 $403,900.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 5

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,800

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC Exercise / conversionCommon Stock 10,000 $57.40 $574,000.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 4

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC SaleCommon Stock 20,000 $58.07 $1,161,368.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 3

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 362,800

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC Exercise / conversionCommon Stock 124,800 $55.39 $6,912,672.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 2

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2005 Filed Apr 27, 2005 18:13 UTC Exercise / conversionCommon Stock 27,000 $31.07 $838,890.00
Disclosure

SEC source: 0001181431-05-023813 · rrd76789.xml · nonDerivative · entry 1

FRITZKY EDWARD V · CIK 0001187892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2005 Filed Apr 4, 2005 21:08 UTC
PERLMUTTER ROGER MExe VP, Research & Development
Tax withholdingCommon Stock 10,979 $57.35 $629,645.65
Disclosure

SEC source: 0001181431-05-020271 · rrd74637.xml · nonDerivative · entry 1

PERLMUTTER ROGER M · CIK 0001184228 · Exe VP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,281

Read SEC document
March 15, 2005 Filed Mar 16, 2005 23:59 UTC
DAYEM HASSANSr. V.P. & Chief Info. Officer
GrantNQSO (Right to Buy) · Derivative 50,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017326 · rrd72669.xml · derivative · entry 1

DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2012-03-15

F1 · derivative.exercise_date: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 00:41 UTC
MORROW GEORGE JExe VP, Global Commercial Ops
GrantNQSO (Right to Buy) · Derivative 75,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017346 · rrd72675.xml · derivative · entry 1

MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2012-03-15

F1 · derivative.exercise_date: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 00:43 UTC
SCOTT DAVID JSr. VP, Gen. Counsel & Secy.
GrantNQSO (Right to Buy) · Derivative 50,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017348 · rrd72670.xml · derivative · entry 1

SCOTT DAVID J · CIK 0001145154 · Sr. VP, Gen. Counsel & Secy.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2012-03-15

F1 · derivative.exercise_date: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 00:45 UTC
MARTIN TIMOTHY OVP, Control Plng & CAO
GrantNQSO (Right to Buy) · Derivative 6,794 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017350 · rrd72671.xml · derivative · entry 2

MARTIN TIMOTHY O · CIK 0001282020 · VP, Control Plng & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,794

Underlying: Common Stock · 6,794 shares

Expires 2012-03-15

F1 · derivative.exercise_date: (TOM 3.15.05) This option is exercisable annually beginning March 15, 2006 as follows: Three equal installments of 2,125 shares and a fourth and last installment of 419 shares.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 00:45 UTC
MARTIN TIMOTHY OVP, Control Plng & CAO
GrantISO (Right to Buy) · Derivative 1,706 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017350 · rrd72671.xml · derivative · entry 1

MARTIN TIMOTHY O · CIK 0001282020 · VP, Control Plng & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,706

Underlying: Common Stock · 1,706 shares

Expires 2012-03-15

Read SEC document
March 15, 2005 Filed Mar 17, 2005 00:46 UTC
SHARER KEVIN WDirector · Chairman of the Bd.CEO & Pres
GrantNQSO (Right to Buy) · Derivative 225,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017351 · rrd72672.xml · derivative · entry 1

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2012-03-15

F1 · derivative.exercise_date: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 00:48 UTC
PERLMUTTER ROGER MExe VP, Research & Development
GrantNQSO (Right to Buy) · Derivative 75,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017354 · rrd72673.xml · derivative · entry 1

PERLMUTTER ROGER M · CIK 0001184228 · Exe VP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2012-03-15

F1 · derivative.exercise_date: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 00:50 UTC
NANULA RICHARD DExe VP Fin, Strat & Comm & CFO
GrantNQSO (Right to Buy) · Derivative 75,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017355 · rrd72674.xml · derivative · entry 1

NANULA RICHARD D · CIK 0001184629 · Exe VP Fin, Strat & Comm & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2012-03-15

F1 · derivative.underlying_shares: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 00:51 UTC
MCNAMEE BRIAN MSr. V.P.,Human Resources
GrantNQSO (Right to Buy) · Derivative 50,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017356 · rrd72676.xml · derivative · entry 1

MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2012-03-15

F1 · derivative.exercise_date: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 00:52 UTC
FENTON DENNIS MEx VP Ops & Corp Compliance
GrantNQSO (Right to Buy) · Derivative 75,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017357 · rrd72668.xml · derivative · entry 1

FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2012-03-15

F1 · derivative.exercise_date: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 01:15 UTC GrantNQSO (Right to Buy) · Derivative 5,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017371 · rrd72847.xml · derivative · entry 3

GLUCK FREDERICK W · CIK 0001184126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2015-03-15

Read SEC document
March 15, 2005 Filed Mar 17, 2005 01:15 UTC GrantRestricted Stock Units 1,706 $0.00 $0.00
Disclosure

SEC source: 0001181431-05-017371 · rrd72847.xml · nonDerivative · entry 2

GLUCK FREDERICK W · CIK 0001184126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,706

F1 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 01:16 UTC GrantNQSO (Right to Buy) · Derivative 5,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017372 · rrd72832.xml · derivative · entry 3

CHOATE JERRY D · CIK 0001099539 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2015-03-15

Read SEC document
March 15, 2005 Filed Mar 17, 2005 01:16 UTC GrantRestricted Stock Units 1,706 $0.00 $0.00
Disclosure

SEC source: 0001181431-05-017372 · rrd72832.xml · nonDerivative · entry 2

CHOATE JERRY D · CIK 0001099539 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,706

F1 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 01:16 UTC GrantNQSO (Right to Buy) · Derivative 5,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017373 · rrd72848.xml · derivative · entry 7

HERRINGER FRANK C · CIK 0001171694 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2015-03-15

Read SEC document
March 15, 2005 Filed Mar 17, 2005 01:16 UTC GrantRestricted Stock Units 1,706 $0.00 $0.00
Disclosure

SEC source: 0001181431-05-017373 · rrd72848.xml · nonDerivative · entry 6

HERRINGER FRANK C · CIK 0001171694 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,706

F1 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 01:17 UTC GrantNQSO (Right to Buy) · Derivative 5,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017374 · rrd72853.xml · derivative · entry 2

JOHNSON FRANKLIN P JR · CIK 0000904017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2015-03-15

Read SEC document
March 15, 2005 Filed Mar 17, 2005 01:17 UTC GrantRestricted Stock Units 1,706 $0.00 $0.00
Disclosure

SEC source: 0001181431-05-017374 · rrd72853.xml · nonDerivative · entry 1

JOHNSON FRANKLIN P JR · CIK 0000904017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,706

F1 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director.

F2 · balance_after: (FPJ 3.15.05) Does not include (i) 712,043 shares held as direct ownership, (ii) 976,627 shares held as indirect ownership by the Revocable Trust, (iii) 600,000 shares held as indirect ownership by Asset Management Partners (the "Partnership"), and (iv) 4 units contractual contingent payment rights held as indirect ownership by the Partnership arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. The reporting person disclaims benefical ownership of the securities held by the Partnership and this report shall not be deemed an admission that the reporting person is the benefical owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934.

Read SEC document
March 15, 2005 Filed Mar 17, 2005 01:18 UTC GrantNQSO (Right to Buy) · Derivative 5,000 $0.00 Strike: $58.61 $0.00
Disclosure

SEC source: 0001181431-05-017375 · rrd72860.xml · derivative · entry 2

OMENN GILBERT S · CIK 0001184227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2015-03-15

Read SEC document
March 15, 2005 Filed Mar 17, 2005 01:18 UTC GrantRestricted Stock Units 1,706 $0.00 $0.00
Disclosure

SEC source: 0001181431-05-017375 · rrd72860.xml · nonDerivative · entry 1

OMENN GILBERT S · CIK 0001184227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,706

F1 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director.

F2 · balance_after: (GSO 3.15.05) Does not include (i) 5,590 shares held as indirect ownership by reporting person's son and (ii) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.